Literature DB >> 28534255

CRISPR/Cas9 system: a powerful technology for in vivo and ex vivo gene therapy.

Xiaohui Zhang1, Liren Wang1, Mingyao Liu2, Dali Li3.   

Abstract

CRISPR/Cas9 is a versatile genome-editing tool which is widely used for modifying the genome of both prokaryotic and eukaryotic organisms for basic research and applications. An increasing number of reports have demonstrated that CRISPR/Cas9-mediated genome editing is a powerful technology for gene therapy. Here, we review the recent advances in CRISPR/Cas9-mediated gene therapy in animal models via different strategies and discuss the challenges as well as future prospects.

Keywords:  CRISPR/Cas9; ex vivo; gene therapy; in vivo

Mesh:

Year:  2017        PMID: 28534255     DOI: 10.1007/s11427-017-9057-2

Source DB:  PubMed          Journal:  Sci China Life Sci        ISSN: 1674-7305            Impact factor:   6.038


  7 in total

1.  Precise, predictable multi-nucleotide deletions in rice and wheat using APOBEC-Cas9.

Authors:  Shengxing Wang; Yuan Zong; Qiupeng Lin; Huawei Zhang; Zhuangzhuang Chai; Dandan Zhang; Kunling Chen; Jin-Long Qiu; Caixia Gao
Journal:  Nat Biotechnol       Date:  2020-06-29       Impact factor: 54.908

Review 2.  Aryl Hydrocarbon Receptor: A New Player of Pathogenesis and Therapy in Cardiovascular Diseases.

Authors:  Tao Yi; Jinxia Wang; Kaixi Zhu; Yaoliang Tang; Shian Huang; Xiaorong Shui; Yuanlin Ding; Can Chen; Wei Lei
Journal:  Biomed Res Int       Date:  2018-06-10       Impact factor: 3.411

Review 3.  Technical advances contribute to the study of genomic imprinting.

Authors:  Yuanyuan Li; Jinsong Li
Journal:  PLoS Genet       Date:  2019-06-20       Impact factor: 5.917

4.  Cas9 Mediated Correction of β-catenin Mutation and Restoring the Expression of Protein Phosphorylation in Colon Cancer HCT-116 Cells Decrease Cell Proliferation in vitro and Hamper Tumor Growth in Mice in vivo.

Authors:  Yanlan Li; Xiangning Li; Jiayao Qu; Dixian Luo; Zheng Hu
Journal:  Onco Targets Ther       Date:  2020-01-06       Impact factor: 4.147

Review 5.  The evolving CRISPR technology.

Authors:  Meng Yan; Jinsong Li
Journal:  Protein Cell       Date:  2019-11       Impact factor: 14.870

6.  Inhibition of HIV-1 replication using the CRISPR/cas9-no NLS system as a prophylactic strategy.

Authors:  Ali Salimi-Jeda; Maryam Esghaei; Farah Bokharaei-Salim; Ali Teimoori; Asghar Abdoli
Journal:  Heliyon       Date:  2022-08-31

7.  Transcriptome Analyses of β-Thalassemia -28(A>G) Mutation Using Isogenic Cell Models Generated by CRISPR/Cas9 and Asymmetric Single-Stranded Oligodeoxynucleotides (assODNs).

Authors:  Jing Li; Ziheng Zhou; Hai-Xi Sun; Wenjie Ouyang; Guoyi Dong; Tianbin Liu; Lei Ge; Xiuqing Zhang; Chao Liu; Ying Gu
Journal:  Front Genet       Date:  2020-10-08       Impact factor: 4.599

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.